Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes
Leen M. ‘t Hart, Nicole Vogelzangs, Dennis O. Mook‐Kanamori, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 103, Iss. 12, pp. 4569-4579
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Gracia Fahed, Laurence Aoun, Morgan Bou Zerdan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 786-786
Open Access | Times Cited: 914
Objectives, design and main findings until 2020 from the Rotterdam Study
M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 5, pp. 483-517
Open Access | Times Cited: 397
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
Donatella Ambroselli, Fabrizio Masciulli, Enrico Romano, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 105
Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia
Pirkko J. Pussinen, Elisa Kopra, Milla Pietiäinen, et al.
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 19-40
Open Access | Times Cited: 84
Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs
Silviu Stanciu, Emilia Rusu, Daniela Miricescu, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 54
Exploratory metabolomics of metabolic syndrome: A status report
Daniella Lent-Schochet, Matthew J. McLaughlin, Neeraj Ramakrishnan, et al.
World Journal of Diabetes (2019) Vol. 10, Iss. 1, pp. 23-36
Open Access | Times Cited: 76
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas
Jun Liu, Lies Lahousse, Michel G. Nivard, et al.
Nature Medicine (2020) Vol. 26, Iss. 1, pp. 110-117
Closed Access | Times Cited: 72
Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment
Julia Hernández-Baixauli, Sergio Quesada‐Vázquez, Roger Mariné-Casadó, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 806-806
Open Access | Times Cited: 55
Daily mycoprotein consumption for 1 week does not affect insulin sensitivity or glycaemic control but modulates the plasma lipidome in healthy adults: a randomised controlled trial
Mariana O. C. Coelho, Alistair J. Monteyne, Marlou L. Dirks, et al.
British Journal Of Nutrition (2020) Vol. 125, Iss. 2, pp. 147-160
Open Access | Times Cited: 46
Omics biomarkers and an approach for their practical implementation to delineate health status for personalized nutrition strategies
Jaap Keijer, Xavier Escoté, Sebastià Galmés, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 23, pp. 8279-8307
Open Access | Times Cited: 16
Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review
Mina Shahisavandi, Kan Wang, Mohsen Ghanbari, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 13
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes
Nete Tofte, Nicole Vogelzangs, Dennis O. Mook‐Kanamori, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 7, pp. 2275-2287
Open Access | Times Cited: 36
Serum metabolomic signatures of gestational diabetes in South Asian and white European women
Claudia Sikorski, Sandi M. Azab, Russell J. de Souza, et al.
BMJ Open Diabetes Research & Care (2022) Vol. 10, Iss. 2, pp. e002733-e002733
Open Access | Times Cited: 19
Harnessing Pharmacomultiomics for Precision Medicine in Diabetes: A Comprehensive Review
Dhoha Dhieb, Dana Mustafa, Maryam Hassiba, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 447-447
Open Access
Atherosclerosis, gut microbiome, and exercise in a meta-omics perspective: a literature review
Haotian Tang, Yanqing Huang, Didi Yuan, et al.
PeerJ (2024) Vol. 12, pp. e17185-e17185
Open Access | Times Cited: 3
Endotoxemia is associated with an adverse metabolic profile
Anne-Mari Määttä, Aino Salminen, Milla Pietiäinen, et al.
Innate Immunity (2020) Vol. 27, Iss. 1, pp. 3-14
Open Access | Times Cited: 25
Multiplatform metabolomics for an integrative exploration of metabolic syndrome in older men
Blandine Comte, Stéphanie Monnerie, Marion Brandolini-Bunlon, et al.
EBioMedicine (2021) Vol. 69, pp. 103440-103440
Open Access | Times Cited: 23
The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus
Anand Thakarakkattil Narayanan Nair, Louise A. Donnelly, Adem Y. Dawed, et al.
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 2
Open Access | Times Cited: 22
1H-NMR metabolomics-based surrogates to impute common clinical risk factors and endpoints
Daniele Bizzarri, Marcel J. T. Reinders, Marian Beekman, et al.
EBioMedicine (2021) Vol. 75, pp. 103764-103764
Open Access | Times Cited: 19
Investigation into potential mechanisms of metabolic syndrome by integrative analysis of metabolomics and proteomics
Meimei Chen, Zhaoyang Yang, Huijian Gan, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0270593-e0270593
Open Access | Times Cited: 14
Metabolomics profiles associated with HbA1c levels in patients with type 2 diabetes
Jun Ho Yun, Heun-Sik Lee, Ho-Yeong Yu, et al.
PLoS ONE (2019) Vol. 14, Iss. 11, pp. e0224274-e0224274
Open Access | Times Cited: 19
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
Najeha Anwardeen, Khaled Naja, Mohamed A. Elrayess
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity
Maxime M. Bos, Raymond Noordam, Kate Bennett, et al.
Metabolomics (2020) Vol. 16, Iss. 3
Open Access | Times Cited: 11
GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers
Daniele Bizzarri, Martijn E.T. Dollé, Bette Loef, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1172-1172
Open Access | Times Cited: 6
Exploration of Metabolomic Markers Associated With Declining Kidney Function in People With Type 2 Diabetes Mellitus
Justina Krasauskaite, Bryan R. Conway, Christopher J. Weir, et al.
Journal of the Endocrine Society (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top